Cyclana Bio

Cyclana Bio is a drug discovery company developing tissue-level therapeutics for endometriosis and women's health conditions.

The company builds whole-tissue disease models using menstrual fluid collected through an observational clinical trial, combined with AI-driven multi-omic data integration to identify novel targets.

Its research focuses on the role of extracellular matrix dysregulation in driving inflammation and tissue dysfunction.

Cyclana Bio's platform is designed to extend beyond endometriosis into other chronic inflammatory diseases sharing similar tissue-level mechanisms.